Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Male pattern baldness does not cause an increased risk of prostate cancer.

CT scans can find serious prostate cancer even when PSA levels are low.

Finasteride may improve prostate cancer treatment outcomes.

Understanding where cancer cells come from helps create better prevention and treatment methods.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

New method finds genetic links between Type 2 Diabetes and Prostate Cancer not seen before.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Cyproterone acetate is used to treat conditions like prostate cancer, early puberty, excessive sexual drive, and female androgenization by affecting androgen functions and suppressing certain hormones.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Six new genetic regions linked to early hair loss also connect to Parkinson's disease and prostate cancer, possibly leading to new treatments.

Finasteride affects frog testes by increasing testosterone, decreasing 5α-DHT, and impacting genes related to reproduction and other functions.

Cyproterone acetate may cause liver cancer at high doses, but is considered safe at recommended doses for approved uses.

Certain drugs that block specific enzymes can help treat prostate diseases.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

The main prostate diseases in dogs are benign growth, infections, and cancer, with various treatments ranging from drugs to surgery, but cancer treatments have limited success.

Finasteride treats enlarged prostate and hair loss, but may cause side effects in some patients.

TGF-β signaling is crucial for stem cell maintenance, differentiation, and has implications for cancer treatment.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

Understanding how epigenetic regulation affects stem cells is key to cancer insights and new treatments.

Hairless mammals have genetic changes in both their protein-coding and regulatory sequences related to hair.

Suppressing very long chain fatty acids is linked to skin cancer.

WNT10B is linked to cancer development and affects survival and disease progression in various cancers.

The triterpenoids from Ganoderma lucidum can block testosterone effects and may help treat enlarged prostate.

Arteannuin might work against cancer and Alzheimer's by targeting neprilysin.